Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

Potential adjuvantic properties of innate immune stimuli

(2014) Hemamali J. Warshakoon et al.   Human vaccines & immunotherapeutics

Design and Synthesis of PotentQuillajaSaponin Vaccine Adjuvants

(2010) Michelle M. Adams et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins

(2010) Govind Ragupathi et al.   VACCINE

Reply to F. Janku et al

(2009) Alexander M.M. Eggermont et al.   JOURNAL OF CLINICAL ONCOLOGY

Advances in saponin-based adjuvants

(2009) Hong-Xiang Sun et al.   VACCINE

Synthesis of QS-21-Xylose: Establishment of the Immunopotentiating Activity of Synthetic QS-21 Adjuvant with a Melanoma Vaccine

(2008) Kai Deng et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

(2008) Salim Abdulla et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

(2008) Pierre Vandepapelière et al.   VACCINE